Kira Bona1, Veronica Dussel2, Liliana Orellana3, Tammy Kang4, Russ Geyer5, Chris Feudtner4, Joanne Wolfe6. 1. Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. 2. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina. 3. Institute of Calculus, School of Sciences, University of Buenos Aires, Buenos Aires, Argentina. 4. The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 5. Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington, DC, USA; Fred Hutchinson Cancer Research Center, Seattle, Washington, DC, USA; University of Washington, Seattle, Washington, DC, USA. 6. Department of Medicine, Boston Children's Hospital, Boston, Massachusetts, USA; Department of Pediatric Hematology/Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: Joanne_wolfe@dfci.harvard.edu.
Abstract
CONTEXT: Despite emerging evidence of substantial financial distress in families of children with complex illness, little is known about economic hardship in families of children with advanced cancer. OBJECTIVES: To describe perceived financial hardship, work disruptions, income losses, and associated economic impact in families of children with advanced cancer stratified by federal poverty level (FPL). METHODS: Cross-sectional survey of 86 parents of children with progressive, recurrent, or nonresponsive cancer at three children's hospitals. Seventy-one families with complete income data (82%) are included in this analysis. RESULTS: Parental work disruptions were prevalent across all income levels, with 67 (94%) families reporting some disruption. At least one parent quit a job because of the child's illness in 29 (42%) families. Nineteen (27%) families described their child's illness as a great economic hardship. Income losses because of work disruptions were substantial for all families; families at or below 200% FPL, however, were disproportionately affected. Six (50%) of the poorest families lost more than 40% of their annual income as compared with two (5%) of the wealthiest families (P = 0.006). As a result of income losses, nine (15%) previously nonpoor families fell from above to below 200% FPL. CONCLUSION: The economic impact of pediatric advanced cancer on families is significant at all income levels, although poorer families suffer disproportionate losses. Development of ameliorative intervention strategies is warranted.
CONTEXT: Despite emerging evidence of substantial financial distress in families of children with complex illness, little is known about economic hardship in families of children with advanced cancer. OBJECTIVES: To describe perceived financial hardship, work disruptions, income losses, and associated economic impact in families of children with advanced cancer stratified by federal poverty level (FPL). METHODS: Cross-sectional survey of 86 parents of children with progressive, recurrent, or nonresponsive cancer at three children's hospitals. Seventy-one families with complete income data (82%) are included in this analysis. RESULTS: Parental work disruptions were prevalent across all income levels, with 67 (94%) families reporting some disruption. At least one parent quit a job because of the child's illness in 29 (42%) families. Nineteen (27%) families described their child's illness as a great economic hardship. Income losses because of work disruptions were substantial for all families; families at or below 200% FPL, however, were disproportionately affected. Six (50%) of the poorest families lost more than 40% of their annual income as compared with two (5%) of the wealthiest families (P = 0.006). As a result of income losses, nine (15%) previously nonpoor families fell from above to below 200% FPL. CONCLUSION: The economic impact of pediatric advanced cancer on families is significant at all income levels, although poorer families suffer disproportionate losses. Development of ameliorative intervention strategies is warranted.
Authors: John A Heath; R Mario Lintuuran; Gemma Rigguto; Nicole Tokatlian; Nicole Tikotlian; Maria McCarthy Journal: Pediatr Hematol Oncol Date: 2006 Jul-Aug Impact factor: 1.969
Authors: Ke Xu; David B Evans; Kei Kawabata; Riadh Zeramdini; Jan Klavus; Christopher J L Murray Journal: Lancet Date: 2003-07-12 Impact factor: 79.321
Authors: Daniel J Zheng; Derek Shyr; Clement Ma; Anna C Muriel; Joanne Wolfe; Kira Bona Journal: Pediatr Blood Cancer Date: 2018-08-01 Impact factor: 3.167
Authors: Erica C Kaye; Jonathan Jerkins; Courtney A Gushue; Samantha DeMarsh; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: J Pain Symptom Manage Date: 2018-02-08 Impact factor: 3.612
Authors: Erica C Kaye; Courtney A Gushue; Samantha DeMarsh; Jonathan Jerkins; April Sykes; Zhaohua Lu; Jennifer M Snaman; Lindsay Blazin; Liza-Marie Johnson; Deena R Levine; R Ray Morrison; Justin N Baker Journal: Pediatr Blood Cancer Date: 2017-12-08 Impact factor: 3.167
Authors: Jordan Gilleland Marchak; Sean N Halpin; Cam Escoffery; Shadé Owolabi; Ann C Mertens; Karen Wasilewski-Masker Journal: Psychooncology Date: 2020-10-20 Impact factor: 3.894
Authors: Matthew P Banegas; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Stephanie Nutt; Loyce Pace; Alexandra Varga; Lisa Waiwaiole; Jennifer Schneider; K Robin Yabroff Journal: J Cancer Surviv Date: 2017-08-29 Impact factor: 4.442